Brain health INnovation Diplomacy: a model binding diverse disciplines to manage the promise and perils of technological innovation.

Alzheimer Disease Dementia Global Health Humans Inventions Technology
Alzheimer’s Brain health dementia depression diplomacy entrepreneurship innovation technology

Journal

International psychogeriatrics
ISSN: 1741-203X
Titre abrégé: Int Psychogeriatr
Pays: England
ID NLM: 9007918

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 6 2 2020
medline: 16 6 2021
entrez: 6 2 2020
Statut: ppublish

Résumé

Brain health diplomacy aims to influence the global policy environment for brain health (i.e. dementia, depression, and other mind/brain disorders) and bridges the disciplines of global brain health, international affairs, management, law, and economics. Determinants of brain health include educational attainment, diet, access to health care, physical activity, social support, and environmental exposures, as well as chronic brain disorders and treatment. Global challenges associated with these determinants include large-scale conflicts and consequent mass migration, chemical contaminants, air quality, socioeconomic status, climate change, and global population aging. Given the rapidly advancing technological innovations impacting brain health, it is paramount to optimize the benefits and mitigate the drawbacks of such technologies. We propose a working model of Brain health INnovation Diplomacy (BIND). We prepared a selective review using literature searches of studies pertaining to brain health technological innovation and diplomacy. BIND aims to improve global brain health outcomes by leveraging technological innovation, entrepreneurship, and innovation diplomacy. It acknowledges the key role that technology, entrepreneurship, and digitization play and will increasingly play in the future of brain health for individuals and societies alike. It strengthens the positive role of novel solutions, recognizes and works to manage both real and potential risks of digital platforms. It is recognition of the political, ethical, cultural, and economic influences that brain health technological innovation and entrepreneurship can have. By creating a framework for BIND, we can use this to ensure a systematic model for the use of technology to optimize brain health.

Sections du résumé

BACKGROUND
Brain health diplomacy aims to influence the global policy environment for brain health (i.e. dementia, depression, and other mind/brain disorders) and bridges the disciplines of global brain health, international affairs, management, law, and economics. Determinants of brain health include educational attainment, diet, access to health care, physical activity, social support, and environmental exposures, as well as chronic brain disorders and treatment. Global challenges associated with these determinants include large-scale conflicts and consequent mass migration, chemical contaminants, air quality, socioeconomic status, climate change, and global population aging. Given the rapidly advancing technological innovations impacting brain health, it is paramount to optimize the benefits and mitigate the drawbacks of such technologies.
OBJECTIVE
We propose a working model of Brain health INnovation Diplomacy (BIND).
METHODS
We prepared a selective review using literature searches of studies pertaining to brain health technological innovation and diplomacy.
RESULTS
BIND aims to improve global brain health outcomes by leveraging technological innovation, entrepreneurship, and innovation diplomacy. It acknowledges the key role that technology, entrepreneurship, and digitization play and will increasingly play in the future of brain health for individuals and societies alike. It strengthens the positive role of novel solutions, recognizes and works to manage both real and potential risks of digital platforms. It is recognition of the political, ethical, cultural, and economic influences that brain health technological innovation and entrepreneurship can have.
CONCLUSIONS
By creating a framework for BIND, we can use this to ensure a systematic model for the use of technology to optimize brain health.

Identifiants

DOI: 10.1017/S1041610219002266 PMID: 32019621 PMC: PMC7423685
pubmed: 32019621
pii: S1041610219002266
doi: 10.1017/S1041610219002266
pmc: PMC7423685
mid: NIHMS1609519
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

955-979

Subventions

Organisme : NIA NIH HHS
ID : U2C AG054397
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG047266
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG008017
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG057234
Pays : United States
Organisme : NCCIH NIH HHS
ID : K24 AT009198
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG051628
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG024978
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG010483
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM109025
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG024978
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Sci Adv. 2019 Jan 09;5(1):eaau4586
pubmed: 30662946
J Prev Alzheimers Dis. 2016;3(3):123-126
pubmed: 29205249
Public Policy Aging Rep. 2017;27(2):53-61
pubmed: 31148911
J Med Internet Res. 2013 May 16;15(5):e97
pubmed: 23681083
Dementia (London). 2019 Mar 25;:1471301219837776
pubmed: 30909718
J Glob Health. 2018 Jun;8(1):010303
pubmed: 29977527
Aging Ment Health. 2018 Jun;22(6):723-729
pubmed: 28513210
Arch Intern Med. 2000 Oct 23;160(19):2964-8
pubmed: 11041904
Environ Int. 2019 May;126:228-233
pubmed: 30822651
Bull World Health Organ. 2017 Nov 1;95(11):749-755
pubmed: 29147055
Neurology. 2018 Jan 30;90(5):222-231
pubmed: 29305437
BMJ Open. 2017 May 17;7(5):e013778
pubmed: 28515187
Alzheimers Dement (N Y). 2015 May;1(1):1-12
pubmed: 26203461
Genet Med. 2011 Jun;13(6):597-605
pubmed: 21577118
Psychiatr Clin North Am. 2015 Sep;38(3):495-514
pubmed: 26300035
Acad Psychiatry. 2016 Aug;40(4):650-8
pubmed: 26983416
Health Psychol. 2001 Jul;20(4):243-55
pubmed: 11515736
Acad Psychiatry. 2017 Feb;41(1):91-99
pubmed: 26964782
J Alzheimers Dis. 2019;70(s1):S145-S163
pubmed: 30775976
Perspect Psychol Sci. 2018 Jul;13(4):473-491
pubmed: 29758166
Int J Bipolar Disord. 2016 Dec;4(1):4
pubmed: 26856996
J Exp Psychol Learn Mem Cogn. 2001 Sep;27(5):1131-46
pubmed: 11550742
Gerontology. 2011;57(4):378-86
pubmed: 20639620
Aust N Z J Psychiatry. 2019 May;53(5):474-475
pubmed: 30754995
Maturitas. 2018 Jul;113:48-52
pubmed: 29903648
Int Psychogeriatr. 2012 Mar;24(3):358-66
pubmed: 22014284
Lancet Glob Health. 2018 Aug;6(8):e824-e825
pubmed: 30012258
Ann Behav Med. 2010 Oct;40(2):218-27
pubmed: 20652462
JMIR Ment Health. 2019 Apr 09;6(4):e12104
pubmed: 30964438
BMJ Glob Health. 2019 Jul 10;4(4):e001548
pubmed: 31354974
Digit Biomark. 2019 May 9;3(2):31-71
pubmed: 32095767
JMIR Mhealth Uhealth. 2016 Aug 02;4(3):e93
pubmed: 27485822
J Neural Transm (Vienna). 2019 Jan;126(1):87-94
pubmed: 29082439
Res Nurs Health. 2018 Jun;41(3):219-227
pubmed: 29504666
Lancet. 2019 Jun 15;393(10189):e42-e43
pubmed: 30482607
Lancet Glob Health. 2019 May;7(5):e561-e562
pubmed: 30904523
Milbank Q. 2011 Sep;89(3):503-23
pubmed: 21933277
BMC Geriatr. 2016 Oct 12;16(1):175
pubmed: 27729011
Trends Cogn Sci. 2009 Oct;13(10):447-54
pubmed: 19726219
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
Alzheimers Dement. 2018 Aug;14(8):1063-1076
pubmed: 29754989
BMJ Open. 2018 Sep 11;8(9):e022404
pubmed: 30206085
Drugs Aging. 2018 Jul;35(7):575-587
pubmed: 30006810
Lancet Neurol. 2014 Aug;13(8):788-94
pubmed: 25030513
Lancet. 2017 Feb 18;389(10070):718-726
pubmed: 28063597
Pharmacogenomics. 2018 Nov;19(16):1269-1284
pubmed: 30422065
J Alzheimers Dis. 2015;44(2):573-84
pubmed: 25310992
Am J Geriatr Psychiatry. 2017 Aug;25(8):873-877
pubmed: 28645535
Lancet Psychiatry. 2018 Jan;5(1):13
pubmed: 29277199
Global Health. 2018 Jun 15;14(1):57
pubmed: 29903036
Neurology. 2019 Aug 6;93(6):e548-e558
pubmed: 31292224
Dement Geriatr Cogn Disord. 2019;47(3):129-130
pubmed: 31234175
Alzheimers Dement. 2018 Feb;14(2):121-129
pubmed: 29233480
J Exp Psychol Learn Mem Cogn. 2017 Dec;43(12):1948-1961
pubmed: 28504531
Sensors (Basel). 2017 Oct 31;17(11):
pubmed: 29088123
J Alzheimers Dis. 2018;64(s1):S47-S105
pubmed: 29562524
Lancet Psychiatry. 2018 Apr;5(4):357-369
pubmed: 29580610
Prog Cardiovasc Dis. 2017 Mar - Apr;59(5):506-521
pubmed: 27546358
Am J Geriatr Psychiatry. 2018 Feb;26(2):125-133
pubmed: 29429869

Auteurs

Kylie Ternes (K)

School of Medicine, Baylor College of Medicine, Houston, Texas, USA.

Vijeth Iyengar (V)

U.S. Administration on Aging/Administration for Community Living, U.S. Department of Health and Human Services, Washington, DC, USA.

Helen Lavretsky (H)

Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, California, USA.

Walter D Dawson (WD)

Memory and Aging Center, School of Medicine, UCSF, San Francisco, California, USA.
Global Brain Health Institute, San Francisco, California, USA.
Trinity College Dublin, Dublin, Ireland.
School of Medicine, Oregon Health and Science University, Portland, Oregon, USA.
Institute on Aging, School of Urban and Public Affairs, Portland State University, Portland, Oregon, USA.

Laura Booi (L)

Global Brain Health Institute, San Francisco, California, USA.
Trinity College Dublin, Dublin, Ireland.

Agustin Ibanez (A)

Memory and Aging Center, School of Medicine, UCSF, San Francisco, California, USA.
Global Brain Health Institute, San Francisco, California, USA.
Trinity College Dublin, Dublin, Ireland.
Institute of Cognitive and Translational Neuroscience (INCYT), INECO Foundation, Favaloro University, Buenos Aires, Argentina.
National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina.
Center for Social and Cognitive Neuroscience (CSCN), Universidad Adolfo Ibanez, Santiago, Chile.
Universidad Autónoma del Caribe, Barranquilla, Colombia.
ARC Centre of Excellence in Cognition and its Disorders, Sydney, Australia.

Ipsit Vahia (I)

McLean Hospital, Belmont, Massachusetts, USA.
Harvard Medical School, Cambridge, Massachusetts, USA.

Charles Reynolds (C)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Steven DeKosky (S)

McKnight Brain Institute and Department of Neurology, College of Medicine, University of Florida, Miami, Florida, USA.

Jeffrey Cummings (J)

Department of Brain Health, School of Integrated Health Sciences, Cleveland Clinic Lou Ruvo Center for Brain Health, UNLV, Las Vegas, Nevada, USA.

Bruce Miller (B)

Memory and Aging Center, School of Medicine, UCSF, San Francisco, California, USA.
Global Brain Health Institute, San Francisco, California, USA.
Trinity College Dublin, Dublin, Ireland.

Carla Perissinotto (C)

Division of Geriatrics, School of Medicine, UCSF, San Francisco, California, USA.

Jeffrey Kaye (J)

School of Medicine, Oregon Health and Science University, Portland, Oregon, USA.

Harris A Eyre (HA)

Innovation Institute, Texas Medical Center, Houston, Texas, USA.
Department of Psychiatry, University of Melbourne, Melbourne, Victoria, Australia.
IMPACT SRC, School of Medicine, Deakin University, Geelong, Victoria, Australia.
Brainstorm Laboratory for Mental Health Innovation, Department of Psychiatry, Stanford University School of Medicine, Palo Alto, California, USA.
Discipline of Psychiatry, School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Troubles mentaux › Troubles neurocognitifs › Démence › Maladie d'Alzheimer › Brain health INnovation Diplomacy: a model...
questionsmedicales.fr › Troubles mentaux › Troubles neurocognitifs › Démence › Brain health INnovation Diplomacy: a model...
questionsmedicales.fr › Caractéristiques de la population › Santé › Santé mondiale › Brain health INnovation Diplomacy: a model...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Brain health INnovation Diplomacy: a model...
questionsmedicales.fr › Technologie, industrie et agriculture › Technologie › Inventions › Brain health INnovation Diplomacy: a model...
questionsmedicales.fr › Technologie, industrie et agriculture › Technologie › Brain health INnovation Diplomacy: a model...